SCOPUS 정보 검색 플랫폼

American Journal of Health-System Pharmacy

Volumn 66, Issue SUPPL. 6, 2009, Pages

Novel combinations for treating metastatic breast cancer: Improving the odds: Introduction

(2) Joanna, Schwartz a Wong, Serena T a,b

a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES (United States)

b RUTGERS CANCER INSTITUTE OF NEW JERSEY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IXABEPILONE; LAPATINIB; TRASTUZUMAB; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT;

BREAST CANCER; BREAST METASTASIS; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOGENESIS; EDITORIAL; GENE EXPRESSION; HORMONAL THERAPY; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; BREAST NEOPLASMS; DRUG DELIVERY SYSTEM; DRUG EFFECTS; FEMALE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL PRODUCTS; BREAST NEOPLASMS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; SIGNAL TRANSDUCTION;

EID: 73649132661 PISSN: 10792082 EISSN: None Source Type: Journal
DOI: None Document Type: Editorial

Times cited : (2)

References (9)

1
- 67650385302
- American Cancer Society. (accessed 2009 Jul 13)
- American Cancer Society. Cancer facts and figures 2009. www.cancer.org/downloads/STT/500809web.pdf (accessed 2009 Jul 13).
- Cancer Facts and Figures 2009

2
- 31444447160
- Extending survival with chemotherapy in metastatic breast cancer
- DOI 10.1634/theoncologist.10-90003-20
- O'Shaughnessy J. Extending survival with chemotherapy in metastatic breast cancer. Oncologist. 2005; 10(suppl 3):20-29 (Pubitemid 43152727)
- (2005) Oncologist , vol.10 , Issue.SUPPL. 3 , pp. 20-29
- O'Shaughnessy, J.¹

3
- 73649092977
- American Cancer Society. (accessed 2009 Jul 23)
- American Cancer Society. New drugs improve survival for metastatic breast cancer. www.cancer.org/docroot/MED/content/MED-2-1x-New-Drugs-Improve-Survival- for-Metastatic-Breast-Cancer.asp (accessed 2009 Jul 23).
- New Drugs Improve Survival for Metastatic Breast Cancer

4
- 43749090834
- Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
- Letter
- Thomas ES. Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. J Clin Oncol. 2008; 26:2223. Letter.
- (2008) J Clin Oncol , vol.26 , pp. 2223
- Thomas, E.S.¹

5
- 33845886440
- Lapatinib plus capecitabine for HER2-positive advanced breast cancer
- DOI 10.1056/NEJMoa064320
- Geyer CE, Forster J, Lindquist D et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med. 2006; 355:2733-2743 (Pubitemid 46021510)
- (2006) New England Journal of Medicine , vol.355 , Issue.26 , pp. 2733-2743
- Geyer, C.E.¹ Forster, J.² Lindquist, D.³ Chan, S.⁴ Romieu, C.G.⁵ Pienkowski, T.⁶ Jagiello-Gruszfeld, A.⁷ Crown, J.⁸ Chan, A.⁹ Kaufman, B.¹⁰ Skarlos, D.¹¹ Campone, M.¹² Davidson, N.¹³ Berger, M.¹⁴ Oliva, C.¹⁵ Rubin, S.D.¹⁶ Stein, S.¹⁷ Cameron, D.¹⁸

6
- 67049133438
- Treatment options for breast cancer resistant to anthracycline and taxane
- Moreno-Aspitia A, Perez EA. Treatment options for breast cancer resistant to anthracycline and taxane. Mayo Clin Proc. 2009; 84:533-545
- (2009) Mayo Clin Proc , vol.84 , pp. 533-545
- Moreno-Aspitia, A.¹ Perez, E.A.²

7
- 13844273459
- Trastuzumab in breast cancer
- Emens LA, Davidson NE. Trastuzumab in breast cancer. Oncology. 2004; 18:1117-1128
- (2004) Oncology , vol.18 , pp. 1117-1128
- Emens, L.A.¹ Davidson, N.E.²

8
- 63449113187
- Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment
- Dworkin AM, Huang TH, Toland AE. Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol. 2009; 19:165-171
- (2009) Semin Cancer Biol , vol.19 , pp. 165-171
- Dworkin, A.M.¹ Huang, T.H.² Toland, A.E.³

9
- 45549095381
- Caring for the treatment-experienced breast cancer patient: The pharmacist's role
- Barbour SY. Caring for the treatment-experienced breast cancer patient: the pharmacist's role. Am J Health-Syst Pharm. 2008; 65(suppl 3):S16-22.
- (2008) Am J Health-Syst Pharm , vol.65 , Issue.SUPPL. 3
- Barbour, S.Y.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.